Hematologic Oncology Update cover image

What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma

Hematologic Oncology Update

00:00

Toxicity and Comparative Analysis of BTK Inhibitors in Mantle Cell Lymphoma

This chapter discusses the toxicity of pertubutinib and covalent btk inhibitors in the treatment of Mantle cell lymphoma, including the common toxicities associated with btk inhibitors and the ongoing study comparing pertubutinib with covalent btk inhibitors to determine comparative toxicity.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app